Rifampicin drug used in TB treatment is expected to be commissioned later this year

Mar 17, 2025

The drug Rifampicin, which is used in serious bacterial infections, particularly Tuberculosis, is expected to be commissioned this year.

Shorter all-oral regimens for drug-resistant TB are cost-effective in India: ICMR study

Feb 12, 2026

An economic evaluation published in the Indian Journal of Medical Research has demonstrated that shorter, six-month all-oral treatment regimens for multidrug-resistant and rifampicin-resistant tuberculosis...

Tuberculosis cases surged for the first time in many years: WHO

Oct 28, 2022

The burden of drug-resistant TB (DR-TB) also increased by 3 per cent between 2020 and 2021, with 450 000 new cases of rifampicin-resistant TB...